» Articles » PMID: 38862231

Using Cerebrospinal Fluid Nanopore Sequencing Assay to Diagnose Tuberculous Meningitis: a Retrospective Cohort Study in China

Overview
Journal BMJ Open
Specialty General Medicine
Date 2024 Jun 11
PMID 38862231
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aimed to evaluate the efficiency of nanopore sequencing for the early diagnosis of tuberculous meningitis (TBM) using cerebrospinal fluid and compared it with acid-fast bacilli (AFB) smear, mycobacterial growth indicator tube culture and Xpert (MTB)/rifampicin (RIF).

Design: Single-centre retrospective study.

Setting: The Tuberculosis Diagnosis and Treatment Center of Zhejiang Chinese and Western Medicine Integrated Hospital.

Participants: We enrolled 64 adult patients with presumptive TBM admitted to our hospital from August 2021 to August 2023.

Methods: We calculated the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of AFB smear, culture, Xpert MTB/RIF and nanopore sequencing to evaluate their diagnostic efficacy compared with a composite reference standard for TBM.

Results: Among these 64 patients, all tested negative for TBM by AFB smear. The sensitivity, specificity, PPV and NPV were 11.11%, 100%, 100% and 32.2% for culture, 13.33%, 100%, 100% and 2.76% for Xpert MTB/RIF, and 77.78%, 100%, 100% and 65.52% for nanopore sequencing, respectively.

Conclusion: The diagnostic accuracy of the nanopore sequencing test was significantly higher than that of conventional testing methods used to detect TBM.

Citing Articles

Epidemiology, Pathogenesis, Clinical Manifestations, and Management Strategies of Tuberculous Meningitis.

Oo N, Agrawal D Arch Intern Med Res. 2025; 8(1):48-58.

PMID: 40061519 PMC: 11887623. DOI: 10.26502/aimr.0195.


Nanopore-targeted sequencing (NTS) for intracranial tuberculosis: a promising and reliable approach.

Yang C, Wang T, Guo Y, Zeng Y, Gao W Ann Clin Microbiol Antimicrob. 2024; 23(1):89.

PMID: 39385187 PMC: 11466032. DOI: 10.1186/s12941-024-00751-x.

References
1.
Huynh J, Donovan J, Phu N, Nghia H, Thuong N, Thwaites G . Tuberculous meningitis: progress and remaining questions. Lancet Neurol. 2022; 21(5):450-464. DOI: 10.1016/S1474-4422(21)00435-X. View

2.
Horiba K, Torii Y, Aizawa Y, Yamaguchi M, Haruta K, Okumura T . Performance of Nanopore and Illumina Metagenomic Sequencing for Pathogen Detection and Transcriptome Analysis in Infantile Central Nervous System Infections. Open Forum Infect Dis. 2022; 9(10):ofac504. PMC: 9587384. DOI: 10.1093/ofid/ofac504. View

3.
Thwaites G, Chau T, Farrar J . Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol. 2004; 42(1):378-9. PMC: 321694. DOI: 10.1128/JCM.42.1.378-379.2004. View

4.
Hyeon J, Li S, Mann D, Zhang S, Li Z, Chen Y . Quasimetagenomics-Based and Real-Time-Sequencing-Aided Detection and Subtyping of Salmonella enterica from Food Samples. Appl Environ Microbiol. 2017; 84(4). PMC: 5795075. DOI: 10.1128/AEM.02340-17. View

5.
Mai N, Thwaites G . Recent advances in the diagnosis and management of tuberculous meningitis. Curr Opin Infect Dis. 2016; 30(1):123-128. DOI: 10.1097/QCO.0000000000000331. View